27 results
6-K
EX-99.2
LSB
LakeShore Biopharma Co., Ltd
7 May 24
Report of Foreign Private Issuer
4:30pm
, that the Company is hereby authorized and directed to conduct an independent investigation of any alleged misconduct and/or illegal activities
6-K
EX-99.1
LSB
LakeShore Biopharma Co., Ltd
22 Feb 24
Report of Foreign Private Issuer
5:06pm
resolution, that the Company is hereby authorized and directed to conduct an independent investigation of any alleged misconduct and/or illegal activities
6-K
EX-99.1
0t7lssej o85r
14 Feb 24
Report of Foreign Private Issuer
8:05am
6-K
EX-99.4
s1ru9i6g
14 Feb 24
Report of Foreign Private Issuer
8:05am
6-K
EX-99.2
edco3jgacrnklyk8
14 Feb 24
Report of Foreign Private Issuer
8:05am
6-K
EX-99.3
czjvz
14 Feb 24
Report of Foreign Private Issuer
8:05am
POS AM
kf7al00folxb1
23 Jan 24
Prospectus update (post-effective amendment)
4:18pm
424B3
jpy9ic646 dph7s
15 Aug 23
Prospectus supplement
8:00am
POS AM
4cz30 qogm8fkn
8 Aug 23
Prospectus update (post-effective amendment)
4:06pm
20-F
rse65hh
26 Jul 23
Annual report (foreign)
4:02pm
424B3
jg4876rbomxw5sbt58d
5 Jun 23
Prospectus supplement
4:03pm
F-1/A
9ed htguetlz4u
12 May 23
Registration statement (foreign) (amended)
4:05pm
F-1
ebuw3
12 Apr 23
Registration statement (foreign)
8:49am
F-4
EX-99.2
4t3oao33ml539bxqqti
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
EX-10.6
52p66eqor
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
cujlg62o398cp zuv
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
EX-10.9
uac42ucxp
28 Dec 22
Registration of securities (foreign)
6:58am